-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Neurocrine Biosciences, Raises Price Target to $198

Benzinga·12/17/2025 12:49:23
語音播報
HC Wainwright & Co. analyst Andrew S. Fein maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Buy and raises the price target from $168 to $198.